Elective unloading with a microaxial flow pump showed no material difference in outcomes versus standard care in severe left ventricular dysfunction
Heart Pump Strategy Backfires for Weakened Hearts During High-Risk Surgery
This randomized controlled trial enrolled 300 patients with severe left ventricular dysfunction and extensive coronary artery disease underg…
A heart pump meant to protect weakened hearts during surgery may increase death risk for patients with severe heart damage, new evidence sug…
Transendocardial ProtheraCytes injections improved physical functioning and vitality in patients with recent large AMI and LV dysfunction
New cell injections help heart patients feel better for six months
This phase I/IIb randomized controlled trial enrolled 31 treated and 12 control patients with recent large myocardial infarction and left ve…
Patients with recent heart attacks and weak heart pumps felt significantly better physically and socially after receiving new cell injection…
Statistical Analysis Plan Defines ICD Insertion Based on Ventricular Scar for Left Ventricular Systolic Dysfunction
New Heart Scan Strategy May Reduce Sudden Death Risk
This document is a statistical analysis plan outlining methods for a trial involving patients with mild moderate left ventricular systolic d…
A new trial plan tests if heart scans can better decide who needs a life-saving device to prevent sudden cardiac death.
Non-randomized preprint on dapagliflozin and epicardial adipose tissue in HFpEF
Dapagliflozin linked to fat loss in heart failure patients
This preprint reports a non-randomized clinical trial in 60 patients with left ventricular diastolic dysfunction.
Adding dapagliflozin to standard care reduced epicardial fat in a small group of heart failure patients, though this preprint study needs co…
Diastolic Age predicts MACE and discriminates LVDD in heart failure cohorts
Doctors Can Now Measure Your Heart’s True Age With One Scan
This cohort study involving 1,952 participants from the Project Baseline Health Study, 1,708 from WASE, and 313 from Stanford Cardiovascular…
A new scan tool calculates your heart's biological age to spot hidden risks before symptoms appear, though it is still experimental.